Results 111 to 120 of about 57,654 (328)

COVID-19 Vaccine Hesitancy and Information Diffusion: An Agent-based Modeling Approach [PDF]

open access: yesarXiv, 2021
Despite the unprecedented success in the rapid development of several effective vaccines against the Cov-SARS-2, global vaccination rollout efforts suffer from vaccine distribution inequality and vaccine acceptance, leading to insufficient public immunity provided by the vaccine products.
arxiv  

A cross-sectional study exploring the predictors of herpes zoster vaccination for people aged over 50 years old in Chaoyang district, Beijing

open access: yesFrontiers in Public Health
BackgroundVaccination is an effective measure to prevent herpes zoster and its related complications. The coverage of herpes zoster vaccination is extremely low in China, and there is a notable lack of research investigating the barriers to promoting the
Jiao Zhang   +10 more
doaj   +1 more source

Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. [PDF]

open access: yes, 2016
To analyze the clinical presentation and complications of varicella zoster virus (VZV) infection in children with rheumatic diseases treated with immunosuppressive medication such as biological disease-modifying antirheumatic drugs (bDMARDs) and/or ...
Aeschlimann, F.   +9 more
core   +2 more sources

Lichen Planus Following COVID‐19 Infection and Vaccination. Matched Case–Control Study

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background New‐onset lichen planus (LP) development following COVID‐19 infection/vaccination is reported. Since case series cannot be used to study exposure–outcome associations, we designed this matched case–control study to investigate whether COVID‐19‐related events and de novo LP are associated.
Paolo Giacomo Arduino   +4 more
wiley   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

Update on andrological effects of SARS‐CoV‐2 infection and COVID‐19: An overview review

open access: yesAndrology, EarlyView.
Abstract Background Evidence indicates a wide range of andrological alterations in patients with the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS‐CoV‐2) infection and Coronavirus Disease 2019 (COVID‐19). Aim To provide an update on the andrological effects of SARS‐CoV‐2 infection and COVID‐19.
Giuseppe Lisco   +7 more
wiley   +1 more source

The alternative fact of probable vaccine damage A typology of vaccination beliefs in 28 European countries [PDF]

open access: yesarXiv, 2021
Background: Despite lacking scientific support, vaccine hesitancy is widespread. While vaccine damage as a scientific fact is statistically highly uncommon, emerging social and technological forces have converted probable vaccine damage into an alternative fact.
arxiv  

Herpes zoster: Epidemiological Features of the Incidence in 2019

open access: yesЭпидемиология и вакцинопрофилактика, 2020
The urgency of the problem of herpes zoster (shingles) consists in its wide distribution in the world, high incidence rates in a significant part of the subjects of the Russian Federation, as well as the severity of complications caused by this infection.
A. N. Kaira, V. F. Lavrov
doaj   +1 more source

Study of the Clinical Patterns in Varicella in a Tertiary Hospital at Coastal Karnataka [PDF]

open access: yes, 2011
Context: There are very few studies regarding the clinical patterns and manifestations of a very common viral infection, Varicella, especially from south India.
Girish, PN   +3 more
core  

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In total 169 patients already exposed to a JAKi and who received a second JAKi were retrospectively studied across 28 GETAID centres, with 48% reaching steroids‐free clinical remission after induction. Adverse events led to treatment discontinuation in 5% of cases.
Mathilde Osty   +56 more
wiley   +1 more source

Home - About - Disclaimer - Privacy